CXCR2 and rhabdomyosarcoma: In rhabdomyosarcoma, where MDSCs of the CXCR2+ CD11b+ Ly6Ghigh phenotype mediated local immune suppression, the efficacy of antibodies directed to PD-1 was augmented when tumor-bearing mice had myeloid cells deficient in CXCR2 (123).